🔗 Permalink

Assignee profile:

LENTIGEN TECHNOLOGY, INC.

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

Last publication date:

2024-03-21

Patent Grants:

Last grant date:

2025-11-11

Top Inventors for applications by LENTIGEN TECHNOLOGY, INC.

These are the the leading inventors for applications assigned to LENTIGEN TECHNOLOGY, INC.:

Dina Schneider 40 Potomac, MD United States
Boro Dropulic 35 Ellicott City, MD United States
Rimas J. Orentas 23 Seattle, WA United States
Zhongyu Zhu 20 Frederick, MD United States

Dimiter S. Dimitrov 17 Frederick, MD United States
Rimas Orentas 7 Washington, DC United States
Peirong Hu 5 Ijamsville, MD United States
Stefan Miltenyi 5 Bergisch-Gladbach, Germany

Waleed M. Haso 4 Fair Lawn, NJ United States
Boro Dropulic 3 Gaithersburg, MD United States
Rimas Orentas 3 Seattle, WA United States
Bang Khoa Vu 2 Frederick, MD United States

Kim Anthony Gonda 2 Gaithersburg, MD United States
Winfried Krueger 2 Kensington, MD United States
Leah Marie Alabanza 2 Montgomery Village, MD United States
Rafijul Bari 1 Rockville, MD United States

Brittany Steimle 1 Gaithersburg, MD United States
Tri Minh Tran 1 Frederick, MD United States
Brian Robert Webster 1 Cologne, Germany
Boro Dropulic 1 Ellicott, MD United States

Aldo Sotelo 1 Sandy, UT United States
Florian Tomszak 1 Bergisch Gladbach, Germany
Rimas J. Orentas 1 Washington, DC United States
Brian Robert Webster 1 Koln, Germany

Waleed M. Haso 1 Santa Monica, CA United States
Terry James Fry 1 Denver, CO United States

Recent patent applications by LENTIGEN TECHNOLOGY, INC.

LENTIGEN TECHNOLOGY, INC. based in Gaithersburg, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-03-21 ✅ Patent 12,465,641 granted on 2025-11-11

US20240091360A1

Human necessities

Chimeric Antigen Receptor Therapies for Treating Solid Tumors

#2 | 2024-02-29 ✅ Patent 12,624,104 granted on 2026-05-12

US20240067724A1

Chemistry; metallurgy

Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy

#3 | 2023-02-28 ✅ Patent 11,590,169 granted on 2023-02-28

US17685132

Human necessities

Compositions and methods for treating cancer with anti-CD123 immunotherapy

#4 | 2022-12-08 ✅ Patent 12,540,179 granted on 2026-02-03

US20220389094A1

Chemistry; metallurgy

Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy

#5 | 2022-10-13 ✅ Patent 12,371,490 granted on 2025-07-29

US20220324967A1

Chemistry; metallurgy

Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy

#6 | 2022-06-02 ✅ Patent 12,365,718 granted on 2025-07-22

US20220169698A1

Chemistry; metallurgy

Compositions and Methods for Treating Cancer with DuoCARs

#7 | 2022-06-02 ✅ Patent 11,969,443 granted on 2024-04-30

US20220168344A1

Human necessities

Compositions and methods for treating cancer with self-driving chimeric antigen receptors

#8 | 2021-12-09 ✅ Patent 11,497,770 granted on 2022-11-15

US20210379110A1

Human necessities

Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy

#9 | 2021-11-25 ✅ Patent 12,391,740 granted on 2025-08-19

US20210361709A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-BCMA IMMUNOTHERAPY

#10 | 2021-11-18 ✅ Patent 12,391,958 granted on 2025-08-19

US20210353675A1

Human necessities

Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy

#11 | 2021-07-08 ✅ Patent 12,024,554 granted on 2024-07-02

US20210206839A1

Chemistry; metallurgy

Compositions and methods for treating HIV/AIDS with immunotherapy

#12 | 2021-06-10 ✅ Patent 11,242,389 granted on 2022-02-08

US20210171633A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

#13 | 2021-06-10 ✅ Patent 12,122,831 granted on 2024-10-22

US20210171632A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

#14 | 2021-05-06 ✅ Patent 12,037,403 granted on 2024-07-16

US20210130479A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD123 immunotherapy

#15 | 2020-12-17 ✅ Patent 11,802,142 granted on 2023-10-31

US20200392200A1

Chemistry; metallurgy

Compositions and methods for treating cancer with DuoCARs

#16 | 2020-09-24 ✅ Patent 12,193,995 granted on 2025-01-14

US20200297769A1

Human necessities

Method to treat cancer with engineered T-cells

#17 | 2020-09-17 ✅ Patent 11,052,112 granted on 2021-07-06

US20200289572A1

Human necessities

Compositions and methods for treating cancer with anti-BCMA immunotherapy

#18 | 2020-07-23 ✅ Patent 11,970,528 granted on 2024-04-30

US20200231663A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

#19 | 2020-07-23 ✅ Patent 11,208,455 granted on 2021-12-28

US20200231648A1

Chemistry; metallurgy

Compositions and methods for treating cancer with DuoCARs

#20 | 2020-06-25 ✅ Patent 11,103,533 granted on 2021-08-31

US20200197440A1

Human necessities

Compositions and methods for treating cancer with anti-CD38 immunotherapy

#21 | 2020-05-21 ✅ Patent 11,878,052 granted on 2024-01-23

US20200155661A1

Human necessities

Compositions and methods for treating cancer with anti-CD22 immunotherapy

#22 | 2020-04-23 ✅ Patent 11,708,408 granted on 2023-07-25

US20200123254A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19 immunotherapy

#23 | 2020-04-09 ✅ Patent 11,680,103 granted on 2023-06-20

US20200109210A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

#24 | 2020-04-02 ✅ Patent 11,453,719 granted on 2022-09-27

US20200102385A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

#25 | 2020-04-02 ✅ Patent 11,464,801 granted on 2022-10-11

US20200101109A1

Human necessities

Compositions and methods for treating cancer with anti-CD33 immunotherapy

#26 | 2020-03-19 ✅ Patent 10,822,412 granted on 2020-11-03

US20200087396A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

#27 | 2020-03-12 ✅ Patent 11,905,515 granted on 2024-02-20

US20200079849A1

Chemistry; metallurgy

Chimeric antigen receptors and methods of use

#28 | 2020-01-09 ✅ Patent 10,844,128 granted on 2020-11-24

US20200010555A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD123 immunotherapy

#29 | 2019-08-08 ✅ Patent 11,453,712 granted on 2022-09-27

US20190241641A1

Chemistry; metallurgy

Compositions and methods for treating cancer with DuoCARs

#30 | 2019-07-18 ✅ Patent 10,550,179 granted on 2020-02-04

US20190218280A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

#31 | 2019-07-04 ✅ Patent 10,894,819 granted on 2021-01-19

US20190202895A1

Chemistry; metallurgy

Compositions and methods for treating HIV/AIDS with immunotherapy

#32 | 2019-05-09 ✅ Patent 10,639,329 granted on 2020-05-05

US20190134091A1

Human necessities

Method to treat cancer with engineered T-cells

#33 | 2019-04-11 ✅ Patent 10,501,539 granted on 2019-12-10

US20190106492A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19 immunotherapy

#34 | 2019-04-04 ✅ Patent 10,543,263 granted on 2020-01-28

US20190099476A1

Human necessities

Compositions and methods for treating cancer with anti-CD22 immunotherapy

#35 | 2019-03-21 ✅ Patent 10,689,431 granted on 2020-06-23

US20190083596A1

Human necessities

Compositions and methods for treating cancer with DuoCARs

#36 | 2019-02-21 ✅ Patent 10,428,141 granted on 2019-10-01

US20190055309A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

#37 | 2018-12-13 ✅ Patent 10,442,867 granted on 2019-10-15

US20180355052A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

#38 | 2018-10-25 ✅ Patent 10,421,810 granted on 2019-09-24

US20180305452A1

Chemistry; metallurgy

Chimeric antigen receptors and methods of use

#39 | 2018-10-04 ✅ Patent 10,426,797 granted on 2019-10-01

US20180280438A1

Human necessities

Compositions and methods for treating cancer with anti-CD33 immunotherapy

#40 | 2018-07-26 ✅ Patent 10,183,993 granted on 2019-01-22

US20180208645A1

Chemistry; metallurgy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Also check out Lentigen Technology, Inc.'s (Gaithersburg, United States) applicant profile with 48 patent applications submitted.

AssigneeID:

347958 ⎘